Peroxisome Elevation Induces Stem Cell Differentiation and Intestinal Epithelial Repair

Area of Science:

• Cell Biology
• Gastroenterology
• Molecular Medicine

Background:

• Mucosal healing (MH) is crucial for inflammatory bowel disease (IBD) patient outcomes.
• The mechanisms driving intestinal epithelial repair in IBD remain largely undefined.
• Peroxisome upregulation was observed in injured intestinal crypts of IBD patients.

Purpose of the Study:

• To elucidate the role of peroxisomes in intestinal epithelial repair.
• To investigate the molecular pathways linking peroxisomes to stem cell regeneration.
• To explore peroxisome-modulating drugs as a potential therapy for IBD.

Main Methods:

• Utilized Drosophila midgut models to study peroxisome function.
• Investigated the involvement of RAB7, Janus Kinase (JAK)/Signal Transducer and Activator of Transcription (STAT), and SOX21A signaling.
• Employed dextran sulfate sodium (DSS)-induced colitis mouse models to assess therapeutic efficacy.

Main Results:

• Increased peroxisomes in Drosophila enhanced RAB7-dependent endosome maturation and stem/progenitor cell differentiation.
• Peroxisome elevation modulated JAK/STAT-SOX21A signaling, promoting intestinal stem cell (ISC)-mediated regeneration.
• RAB7 and SOX21 were upregulated in IBD patient crypts.
• Peroxisome-boosting drugs ameliorated DSS-induced colitis symptoms in mice.

Conclusions:

• Peroxisomes play a critical role in epithelial repair and mucosal healing.
• A novel peroxisome-mediated pathway involving RAB7 and JAK/STAT-SOX21A signaling drives intestinal regeneration.
• Targeting peroxisome levels presents a promising therapeutic strategy for enhancing mucosal healing in IBD.